Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke (multiple letter) [1]

Journal of the Neurological Sciences

Volumn 150, Issue 1, 1997, Pages 85-87

  Rosendaal, F R ^a   Algra, A ^a   Diener, H C ^a   Lowenthal, A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE;

CLINICAL TRIAL; HUMAN; LETTER; PRIORITY JOURNAL; STROKE;

EID: 0030844573     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)05416-6     Document Type: Article

References (3)

1. Antiplatelet Trialists' Collaboration (1994) Collaborative overveiw of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged anti-platelet therapy in various categories of patients. Br. J. Med., 308: 81–106.
2. Cannegieter, S.C., Rosendaal, F.R. and Briët, E. (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation, 89: 635–641.
3. Diener, H.C., Cunha, L., Forbes, C., Sivenius, J., Smets, P. and Lowenthal, A. (1996) European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci., 143: 1–13.